Takeda Pharmaceuticals Australia has notified us that the shortage of Vyvanse 60 mg capsules will be extended until 30 April 2024. The shortage of Vyvanse 40 mg is also expected to resolve on 30 April 2024.
The shortages of Vyvanse 30 mg and 50 mg have resolved and supply has returned to normal.